Identification of novel significant variants of ZFPM2/FOG2 in non-syndromic tetralogy of fallot and double outlet right ventricle in a Chinese Han population

详细信息    查看全文

• 作者：Xiaomin Huang (1)
  Wenquan Niu (2)
  Zhen Zhang (3)
  Chunxia Zhou (1)
  Zhiwei Xu (1)
  Jinfen Liu (1)
  Zhaokang Su (1)
  Wenxiang Ding (1)
  Haibo Zhang (1)
  
• 关键词：ZFPM2/FOG2 ; Tetralogy of Fallot (TOF) ; Double outlet right ventricle (DORV) ; Conotruncal defects (CTDs)
• 刊名：Molecular Biology Reports
• 出版年：2014
• 出版时间：April 2014
• 年：2014
• 卷：41
• 期：4
• 页码：2671-2677
• 全文大小：723 KB
• 参考文献：1. Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39(12):1890-900 CrossRef
  2. Goldmuntz E (2001) The epidemiology and genetics of congenital heart disease. Clin Perinatol 28:1-0 CrossRef
  3. Kuehl KS et al (2005) Genetic and environmental influences on malformations of the cardiac outflow tract. Expert Rev Cardiovasc Ther 3(6):1125-130 CrossRef
  4. Müller AM, Sarioglu N (2012) Congenital heart defects?of the septa, endocardial cushions and the conotruncus. Pathologe 33(3):205-16. doi:10.1007/s00292-011-1557-5 CrossRef
  5. Tevosian SG et al (2000) FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium. Cell 101(7):729-39 CrossRef
  6. Griffin HR et al (2010) Systematic survey of variants in TBX1 in non-syndromic tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variants. Heart 96(20):1651-655. doi:10.1136/hrt.2010.200121 CrossRef
  7. Takahashi K, Kido S et al (1995) Frequency of a 22q11 deletion in patients with conotruncal cardiac malformations: a prospective study. Eur J Pediatr 154(11):878-81 CrossRef
  8. Green way SC et al (2009) De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet 41(8):931-35. doi:10.1038/ng.415 CrossRef
  9. Stennard FA, Costa MW et al (2003) Cardiac T-box factor Tbx20 directly interacts with NKX2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart. Dev Biol 262:206-24 CrossRef
  10. Nemer G, Nemer M (2003) Transcriptional activation of BMP-4 and regulation of mammalian organogenesis by GATA-4 and -6. Dev Biol 254(1):131-48 CrossRef
  11. Tan ZP et al (2011) Novel ZFPM2/FOG2 variants in patients with double outlet right ventricle. Clin Genet 82(5):466-71. doi:10.1111/j.1399-0004.2011.01787.x CrossRef
  12. Zhou P et al (2012) Regulation of GATA4 transcriptional activity in cardiovascular development and disease. Curr Top Dev Biol 100:143-69. doi:10.1016/B978-0-12-387786-4.00005-1 CrossRef
  13. Svensson EC, Tufts RL et al (1999) Molecular cloning of FOG-2: a modulator of transcription factor GATA-4 in cardiomyocytes. Proc Natl Acad Sci USA 96(3):956-61 CrossRef
  14. Pincelli AI, Finelli P (2007) Disruption of friend of GATA 2 gene (FOG-2) by a de novo t(8;10) chromosomal translocation is associated with heart defects and gonadal dysgenesis. Clin Genet 71(3):195-04 CrossRef
  15. De Luca A et al (2011) New mutations in ZFPM2/FOG2 gene in tetralogy of Fallot double outlet right ventricle. Clin Genet 80(2):184-90. doi:10.1111/j.1399-0004.2010.01523.x CrossRef
  16. Zhou B, Ma Q, Kong SW et al (2009) FOG2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart. J Clin Invest 119(6):1462-476. doi:10.1172/JCI38723 CrossRef
  17. Tevosian SG et al (2000) FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium. Cell 101(7):729-39 CrossRef
  18. Anttonen M, Ketola I et al (2003) FOG-2 and GATA-4 Are coexpressed in the mouse ovary and can modulate mullerian-inhibiting substance expression. Biol Reprod 68(4):1333-340 CrossRef
  19. Pizzuti A, Sarkozy A et al (2003) Mutations of ZFPM2/FOG2 gene in sporadic cases of tetralogy of fallot. Hum Mutat 22(5):372-77 CrossRef
  20. Wilkinson JL, Anderson RH et al (1974) Morphogenesis of bulboventricular malformations. II. Observations on malformed hearts. Br Heart J 36(10):948-70 CrossRef
  21. Wilkinson JL, Anderson RH et al (1974) Morphogenesis of bulboventricular malformations. I. Consideration of embryogenesis in the normal heart. Br Heart J 36(3):242-55 CrossRef
  
• 作者单位：Xiaomin Huang (1)
  Wenquan Niu (2)
  Zhen Zhang (3)
  Chunxia Zhou (1)
  Zhiwei Xu (1)
  Jinfen Liu (1)
  Zhaokang Su (1)
  Wenxiang Ding (1)
  Haibo Zhang (1)
  
  1. Heart Center, Shanghai Children’s Medical Center, Shanghai Jiaotong University School of Medicine, Dongfang Road 1678, Shanghai, 200127, China
  2. State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China
  3. Shanghai Pediatric Congenital Heart Disease Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China
  
• ISSN：1573-4978

文摘

Tetralogy of Fallot (TOF) and double outlet right ventricle (DORV) are two common subtypes of conotruncal defects. Recent reports have implicated mutations in the zinc finger protein, FOG family member 2 (ZFPM2/FOG2) as a cause of TOF/DORV, but no current literature focuses on the relationship between ZFPM2/FOG2 gene and non-syndromic TOF and DORV in Chinese Han population. The purpose of this study was to estimate the occurrence and the prevalence of ZFPM2/FOG2 genetic variants in Chinese Han population with non-syndromic TOF and DORV and to investigate genotype–phenotype correlations in individuals with ZFPM2/FOG2 mutations. The whole exons of ZFPM2/FOG2 were sequenced in 98 non-syndromic TOF/DORV patients and 200 control subjects. All the six variants (G2482A, G1552A, A2107C, C452T, C3239T, C1208G) changed the amino acid (p.Val828Met, p.Ala518Thr, p.Met703Leu, p.Thr151Ile, p.Ser1080Phe, p.Ala403Gly), in which four variants (G2482A, C452T, G1552A, C3239T) were not reported before and absent in control subjects. Further analysis revealed that only occurrences of variants G2482A and A2107C had statistical significance compared to the control group (P?<?0.05). In conclusion, our results provide strong evidence regarding the susceptibility of the ZFPM2 gene to the development of non-syndromic TOF/DORV. It suggests that ZFPM2/FOG2 genetic variants may be a novel potential bio-markers and treatment targets for the non-syndromic TOF and DORV.